Composition
- Active ingredients
- CETYL ALCOHOL 12MG/VIAL; COLFOSCERIL PALMITATE 108MG/VIAL; TYLOXAPOL 8MG/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020044.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Exosurf Neonatal
- Active substance
- cetyl alcohol
- Route
- Intratracheal
- Dosage form
- For suspension
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 2 Aug 1990
- Application
- NDA020044-001